GB9114950D0 - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- GB9114950D0 GB9114950D0 GB919114950A GB9114950A GB9114950D0 GB 9114950 D0 GB9114950 D0 GB 9114950D0 GB 919114950 A GB919114950 A GB 919114950A GB 9114950 A GB9114950 A GB 9114950A GB 9114950 D0 GB9114950 D0 GB 9114950D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919114950A GB9114950D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
PCT/GB1992/001207 WO1993000898A1 (fr) | 1991-07-11 | 1992-07-03 | Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau |
JP5502080A JPH06508844A (ja) | 1991-07-11 | 1992-07-03 | ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤 |
EP92914294A EP0593573A1 (fr) | 1991-07-11 | 1992-07-03 | Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau |
AU22306/92A AU2230692A (en) | 1991-07-11 | 1992-07-03 | Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919114950A GB9114950D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9114950D0 true GB9114950D0 (en) | 1991-08-28 |
Family
ID=10698173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919114950A Pending GB9114950D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0593573A1 (fr) |
JP (1) | JPH06508844A (fr) |
AU (1) | AU2230692A (fr) |
GB (1) | GB9114950D0 (fr) |
WO (1) | WO1993000898A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1289084C (zh) | 1995-09-07 | 2006-12-13 | 史密丝克莱恩比彻姆有限公司 | 药物制剂 |
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
DE19706978A1 (de) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
US20010016577A1 (en) * | 1998-08-24 | 2001-08-23 | Douglas Joseph Dobrozsi | Oral mucoadhesive compositions containing gastrointestinal actives |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
WO2002030392A2 (fr) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Nouvelle formulation |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
KR101420446B1 (ko) | 2005-09-22 | 2014-07-16 | 메이지 세이카 파루마 가부시키가이샤 | 메탈로-β-락타마제 저해제 |
TR201000688A2 (tr) | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
EP2568959A2 (fr) | 2010-05-14 | 2013-03-20 | Mahmut Bilgic | Formulations comprenant une céphalosporine et un acide clavulanique de troisième génération |
WO2011142730A1 (fr) | 2010-05-14 | 2011-11-17 | Mahmut Bilgic | Composition pharmaceutique comprenant la céfixime et un composé dérivé de l'acide clavulanique |
EP2575777A1 (fr) | 2010-06-03 | 2013-04-10 | Mahmut Bilgic | Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3266580D1 (en) * | 1981-12-02 | 1985-10-31 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
GB9007945D0 (en) * | 1990-04-07 | 1990-06-06 | Beecham Group Plc | Pharmaceutical formulation |
-
1991
- 1991-07-11 GB GB919114950A patent/GB9114950D0/en active Pending
-
1992
- 1992-07-03 EP EP92914294A patent/EP0593573A1/fr not_active Withdrawn
- 1992-07-03 AU AU22306/92A patent/AU2230692A/en not_active Abandoned
- 1992-07-03 WO PCT/GB1992/001207 patent/WO1993000898A1/fr not_active Application Discontinuation
- 1992-07-03 JP JP5502080A patent/JPH06508844A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1993000898A1 (fr) | 1993-01-21 |
JPH06508844A (ja) | 1994-10-06 |
EP0593573A1 (fr) | 1994-04-27 |
AU2230692A (en) | 1993-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL102777A0 (en) | Pharmaceutical combination formulation | |
ZA923272B (en) | Pharmaceutical formulations | |
IL101679A0 (en) | Pharmaceutical tablet formulation | |
AP9200356A0 (en) | Pharmaceutical composition | |
GB9114950D0 (en) | Pharmaceutical formulation | |
GB9103302D0 (en) | Pharmaceutical formulations | |
ZA92729B (en) | Pharmaceutical agent | |
SG49144A1 (en) | Pharmaceutical formulation | |
GB9216061D0 (en) | Pharmaceutical combination formulation | |
GB9112974D0 (en) | Pharmaceutical formulation | |
GB9122115D0 (en) | Pharmaceutical formulation | |
GB9122114D0 (en) | Pharmaceutical formulation | |
GB9121798D0 (en) | Pharmaceutical formulation | |
GB9116467D0 (en) | Pharmaceutical formulation | |
GB9022280D0 (en) | Pharmaceutical formulation | |
GB9019070D0 (en) | Pharmaceutical formulation | |
GB9013312D0 (en) | Pharmaceutical formulation | |
IE900901L (en) | Pharmaceutical formulation | |
GB9006650D0 (en) | Pharmaceutical formulation | |
IE901206L (en) | Pharmaceutical formulation | |
GB9221694D0 (en) | Pharmaceutical formulation | |
GB9212968D0 (en) | Pharmaceutical formulation | |
GB9114621D0 (en) | Pharmaceutical formulations | |
GB9103444D0 (en) | Pharmaceutical formulations | |
GB9124803D0 (en) | Pharmaceutical formulations |